X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE AUROBINDO PHARMA SUVEN LIFE/
AUROBINDO PHARMA
 
P/E (TTM) x 18.0 19.8 91.0% View Chart
P/BV x 3.6 3.7 97.4% View Chart
Dividend Yield % 0.6 0.3 187.2%  

Financials

 SUVEN LIFE   AUROBINDO PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
AUROBINDO PHARMA
Mar-18
SUVEN LIFE/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs251809 31.0%   
Low Rs155504 30.8%   
Sales per share (Unadj.) Rs49.1281.1 17.5%  
Earnings per share (Unadj.) Rs9.741.4 23.5%  
Cash flow per share (Unadj.) Rs11.450.9 22.4%  
Dividends per share (Unadj.) Rs1.502.50 60.0%  
Dividend yield (eoy) %0.70.4 194.1%  
Book value per share (Unadj.) Rs60.3199.4 30.2%  
Shares outstanding (eoy) m127.28585.88 21.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.3 176.8%   
Avg P/E ratio x20.915.9 131.5%  
P/CF ratio (eoy) x17.812.9 138.0%  
Price / Book Value ratio x3.43.3 102.2%  
Dividend payout %15.46.0 255.3%   
Avg Mkt Cap Rs m25,825384,630 6.7%   
No. of employees `0001.117.3 6.2%   
Total wages/salary Rs m61321,308 2.9%   
Avg. sales/employee Rs Th5,832.69,500.7 61.4%   
Avg. wages/employee Rs Th571.51,229.4 46.5%   
Avg. net profit/employee Rs Th1,153.81,397.9 82.5%   
INCOME DATA
Net Sales Rs m6,253164,666 3.8%  
Other income Rs m2331,020 22.8%   
Total revenues Rs m6,485165,686 3.9%   
Gross profit Rs m1,98237,718 5.3%  
Depreciation Rs m2135,580 3.8%   
Interest Rs m46777 6.0%   
Profit before tax Rs m1,95532,380 6.0%   
Minority Interest Rs m031 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7188,183 8.8%   
Profit after tax Rs m1,23724,229 5.1%  
Gross profit margin %31.722.9 138.4%  
Effective tax rate %36.725.3 145.4%   
Net profit margin %19.814.7 134.4%  
BALANCE SHEET DATA
Current assets Rs m5,622121,878 4.6%   
Current liabilities Rs m1,16886,806 1.3%   
Net working cap to sales %71.221.3 334.5%  
Current ratio x4.81.4 343.0%  
Inventory Days Days81130 62.7%  
Debtors Days Days3668 52.5%  
Net fixed assets Rs m3,32581,037 4.1%   
Share capital Rs m127586 21.7%   
"Free" reserves Rs m7,547116,218 6.5%   
Net worth Rs m7,674116,804 6.6%   
Long term debt Rs m144,512 0.3%   
Total assets Rs m9,135211,052 4.3%  
Interest coverage x43.242.7 101.3%   
Debt to equity ratio x00 4.7%  
Sales to assets ratio x0.70.8 87.7%   
Return on assets %14.011.8 118.5%  
Return on equity %16.120.7 77.7%  
Return on capital %26.027.4 95.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,06680,727 6.3%   
Fx outflow Rs m2,00134,700 5.8%   
Net fx Rs m3,06546,027 6.7%   
CASH FLOW
From Operations Rs m69919,548 3.6%  
From Investments Rs m-6-19,570 0.0%  
From Financial Activity Rs m-5778,642 -6.7%  
Net Cashflow Rs m1168,922 1.3%  

Share Holding

Indian Promoters % 63.4 54.1 117.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 8.0 -  
FIIs % 0.0 27.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.2 357.8%  
Shareholders   37,287 69,601 53.6%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   CADILA HEALTHCARE  TTK HEALTHCARE  MERCK LTD  BIOCON LTD  J.B.CHEMICALS  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 629 Points Higher; Realty and Auto Stocks Witness Buying(Closing)

Indian share markets continued their momentum throughout the day and ended the day on a strong note. Gains were largely seen in the realty sector, telecom sector and auto sector.

Related Views on News

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 21.6% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (down 21.6% YoY). Sales on the other hand came in at Rs 48 bn (up 7.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Dec 12, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS